<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: New Animal Drugs; Cephalexin; Fentanyl; Milbemycin Oxime and Praziquantel</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: New Animal Drugs; Cephalexin; Fentanyl; Milbemycin Oxime and Praziquantel</h1>
    <p class="timestamp">Published: 2012-08-09 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval actions for new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) during June 2012. FDA is also informing the public of the availability of summaries the basis of approval and of environmental review documents, where applicable.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Rule</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2012-19498</p>
    <p><strong>Publication Date:</strong> 2012-08-09</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2012/08/09/2012-19498/new-animal-drugs-cephalexin-fentanyl-milbemycin-oxime-and-praziquantel">https://www.federalregister.gov/documents/2012/08/09/2012-19498/new-animal-drugs-cephalexin-fentanyl-milbemycin-oxime-and-praziquantel</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2012-19498</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
